Covered recipient · General Payments record
MERLE A FILECIA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,485.08
- Reported across 140 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $320.81 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $85.67 | 4 |
| Acerta Pharma LLC | $83.05 | 3 |
| Lilly USA, LLC | $61.48 | 4 |
| Novo Nordisk AS | $51.98 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.10 | 1 |
| Exact Sciences Corporation | $18.53 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.80 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117250982 | CMS |
| Amgen Inc. | $32.28 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117250986 | CMS |
| Amgen Inc. | $20.64 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117250984 | CMS |
| Amgen Inc. | $16.95 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117553355 | CMS |
| AstraZeneca Pharmaceuticals LP | $32.98 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105462614 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.22 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104655443 | CMS |
| AstraZeneca Pharmaceuticals LP | $34.85 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105833617 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.10 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118012909 | CMS |
| Exact Sciences Corporation | $18.53 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114413470 | CMS |
| Lilly USA, LLC | $15.40 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135758274 | CMS |
| Lilly USA, LLC | $14.50 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135746226 | CMS |
| Lilly USA, LLC | $16.07 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135791316 | CMS |
| Lilly USA, LLC | $15.51 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135746224 | CMS |
| Novo Nordisk Inc | $17.46 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100363101 | CMS |
| Novo Nordisk Inc | $14.50 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100319744 | CMS |
| Novo Nordisk Inc | $20.02 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100383957 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.